Laali, Elahe <br/><br/>
Appropriateness of using granulocyte colony-stimulating factor (G-CSF) for primary prophylaxis of febrile neutropenia in solid tumors.  [electronic resource] 

 -  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners  Mar 2020 
 - 428-433 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1477-092X 
<br/><br/><label>Standard No.: </label>10.1177/1078155219875507  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Febrile Neutropenia--diagnosis<br/>Female<br/>Granulocyte Colony-Stimulating Factor--adverse effects<br/>Humans<br/>Inappropriate Prescribing--prevention & control<br/>Male<br/>Middle Aged<br/>Neoplasms--diagnosis<br/>Pre-Exposure Prophylaxis--methods<br/>Prospective Studies<br/>Young Adult